
Ophthalmologists in support of routine vaccinations for herpes zoster (shingles) can take steps to offer their older patients more protection against the ocular complications of the disease.

Ophthalmologists in support of routine vaccinations for herpes zoster (shingles) can take steps to offer their older patients more protection against the ocular complications of the disease.

The decision on IOL type and fixation method in eyes without adequate capsular support should take into account the specific clinical presentation.

A fluid-filled, injectable accommodating IOL demonstrated accommodative and refractive stability in a recent 6-month prospective study.

In this first of a two-part series, Arun C. Gulani, MD, will address the entire corneal aspects of correcting radial keratotomy (RK). The next column will address the lens-based surgeries from phakic to pseudophakic when they are associated with RK correction.

A new method being developed to improve the accuracy of IOL power calculations for cataract surgery uses pattern recognition as its basis.

Kenneth J. Rosenthal, MD, explains the advantages of an add-on sulcus-based IOL for correcting refractive errors in eyes that have undergone cataract surgery with in-the-bag IOL implantation.

The Synchrony dual-optic accommodative intraocular lens (Abbott Medical Optics) seems to be clinically safe and effective after 2 years of follow-up. The visual function at intermediate and far improved rapidly postoperatively. Half of patients require a +1 D prescription for near vision.

A diffractive trifocal IOL is novel technology that delivers good near, intermediate, and far vision and has other advantages.

A new trifocal IOL with double C-loop haptics (Micro F FineVision, PhysIOL) delivers excellent outcomes based on the benefits of its optic features and haptics.

Sriram Hathwar co-won this year’s 87th Annual Scripps National Spell Bee, but the 14-year-old had another one of his dreams come true Friday-to experience what it is like to be an ophthalmologist for a day.

IOP patterns derived from measurements obtained with a non-invasive contact lens sensor (CLS; Triggerfish, Sensimed AG) correlate well with polysomnographic recordings of rapid eye movement (REM) sleep, according to research presented by Kaweh Mansouri, MD, and Tarek Shaarawy, MD.

The ongoing back-and-forth battle to either speed up or halt Valeant Pharmaceuticals International’s hostile takeover attempt of Allergan shows no sign of concluding any time soon.

Researchers in the United Kingdom have demonstrated that advanced DNA testing for congenital cataracts can quickly and accurately diagnose several rare diseases marked by childhood blindness.

African-Americans seem to be at higher risk for diabetic macular edema (DME), according to research by the Keck School of Medicine at the University of Southern California (USC).

A gay teen that committed suicide after being bullied by his classmates had one last wish-to donate his organs. While his kidneys, liver, heart, and lungs were donated, because of an FDA regulation, his eyes were not due to his sexual orientation.

Patient satisfaction is key to maintaining a profitable, credible clinic and giving great customer service to your patients is the best way to make sure they leave your office happy.

EyeCare America-a public service foundation of the American Academy of Ophthalmology-is hoping to inspire young ophthalmologists (YO) to become volunteers with a new initiative.

The creation of a sufficiently long-internal incision as well as stromal hydration and a moderate final IOP are effective steps to reduce fluid ingress-and lower risk of infection-into the eye following cataract surgery, according to Neal Shorstein, MD.

In an attempt to combat the risk of eye infections in contact lens wearers, the American Academy of Ophthalmology (AAO) has joined up with the FDA, the Contact Lens Association of Ophthalmologists, the American Academy of Optometry, and the American Optometric Association.

Alcon Laboratories has introduced two vitrectomy technologies designed to help surgeons deliver a higher level of precision and efficiency during retina surgery.

The American Medical Association (AMA) has asked the Centers for Medicare and Medicaid Services (CMS) to lengthen the timeframe for registering and using the Open Payments system. This would allow physicians enough time to review and seek corrections of inaccurate claims made by pharmaceutical companies, device manufacturers, and group purchasing organizations under the Sunshine Act, the AMS noted.

Research in glaucoma that evaluates the molecular interactions between resident and systemic immune cells and neurons is progressing with the goal of providing translational applications for immunomodulation as a neuroprotective strategy in patients with glaucoma, said Gülgün Tezel, MD.

Genentech has submitted a supplemental Biologics License Application (sBLA) to the FDA for its treatment of diabetic retinopathy, ranibizumab injection (Lucentis).

Nicox S.A. has decided to exercise the option to co-promote its glaucoma and ocular hypertension treatment-latanoprostene bunod-with Bausch + Lomb in the United States.

Kala Pharmaceuticals has initiated a phase II clinical trial to evaluate a nanopartical platform in patients with intraretinal or subretinal fluid secondary to retinal vein occlusion (RVO) or diabetic macular edema (DME).

Ophthotech Corp. has initiated the first of several planned expansion trials, in addition to the ongoing E10030 (Fovista) combination therapy phase III clinical program.

The FDA has approved Regeneron’s aflibercept (Eylea) for the treatment of diabetic macular edema (DME).

Allergan has filed a U.S. lawsuit against Valeant Pharmaceuticals International and Pershing Square Capital Management that alleges insider trading.

Alcon Laboratories’ brinzolamide 10mg/mL and brimonidine tartrate 2mg/mL (Simbrinza) eye drop formulation have been approved by the European Commission to decrease elevated IOP in adult patients with open-angle glaucoma or ocular hypertension.

The Danish Health and Medicines Authority, along with the Norwegian Medicines Evaluation Board, have granted marketing authorization to Alimera Sciences’ Iluvien for the treatment of vision impairment associated with chronic diabetic macular edema (DME) in their respective countries.